Development, testing and reporting of mobile apps for psycho-social interventions: lessons from the pharmaceuticals

The mobile Health offers great potential for delivery of Psycho-social Interventions. So far, the researchers have focused mainly on efficacy, and to some extent feasibility of Psycho-social Interventions. Poor reporting of development and initial testing has been highlighted in the recent published...

Full description

Bibliographic Details
Main Authors: Naeem, Farooq, Syed, Yumeen, Xiang, Shuo, Shokraneh, Farhad, Munshi, Tariq, Yang, Mega, Adams, Clive E., Farooq, Saeed
Format: Article
Published: Omics Publishing Group 2015
Subjects:
Online Access:https://eprints.nottingham.ac.uk/50110/
_version_ 1848798156579405824
author Naeem, Farooq
Syed, Yumeen
Xiang, Shuo
Shokraneh, Farhad
Munshi, Tariq
Yang, Mega
Adams, Clive E.
Farooq, Saeed
author_facet Naeem, Farooq
Syed, Yumeen
Xiang, Shuo
Shokraneh, Farhad
Munshi, Tariq
Yang, Mega
Adams, Clive E.
Farooq, Saeed
author_sort Naeem, Farooq
building Nottingham Research Data Repository
collection Online Access
description The mobile Health offers great potential for delivery of Psycho-social Interventions. So far, the researchers have focused mainly on efficacy, and to some extent feasibility of Psycho-social Interventions. Poor reporting of development and initial testing has been highlighted in the recent published literature. This is not surprising considering the lack of guidance from the national regulatory agencies in developed countries. A lack of standard ways of development and testing of apps makes scientific evaluation of the intervention and replicability almost impossible. Replicabiliy is an essential component of good science. We are proposing a pathway to develop, test and report new mobile apps that deliver Psycho-social Intervention, that is based on current practices of approval of new drugs by the US, Food and Drug Administration (FDA). This proposed process consists of modifications in the current app development process, i.e., planning, alpha and beta testing. We are also suggesting an additional delta stage of testing. We note the advantages and limitations in using such approach.
first_indexed 2025-11-14T20:15:18Z
format Article
id nottingham-50110
institution University of Nottingham Malaysia Campus
institution_category Local University
last_indexed 2025-11-14T20:15:18Z
publishDate 2015
publisher Omics Publishing Group
recordtype eprints
repository_type Digital Repository
spelling nottingham-501102020-05-04T17:25:22Z https://eprints.nottingham.ac.uk/50110/ Development, testing and reporting of mobile apps for psycho-social interventions: lessons from the pharmaceuticals Naeem, Farooq Syed, Yumeen Xiang, Shuo Shokraneh, Farhad Munshi, Tariq Yang, Mega Adams, Clive E. Farooq, Saeed The mobile Health offers great potential for delivery of Psycho-social Interventions. So far, the researchers have focused mainly on efficacy, and to some extent feasibility of Psycho-social Interventions. Poor reporting of development and initial testing has been highlighted in the recent published literature. This is not surprising considering the lack of guidance from the national regulatory agencies in developed countries. A lack of standard ways of development and testing of apps makes scientific evaluation of the intervention and replicability almost impossible. Replicabiliy is an essential component of good science. We are proposing a pathway to develop, test and report new mobile apps that deliver Psycho-social Intervention, that is based on current practices of approval of new drugs by the US, Food and Drug Administration (FDA). This proposed process consists of modifications in the current app development process, i.e., planning, alpha and beta testing. We are also suggesting an additional delta stage of testing. We note the advantages and limitations in using such approach. Omics Publishing Group 2015-12-31 Article PeerReviewed Naeem, Farooq, Syed, Yumeen, Xiang, Shuo, Shokraneh, Farhad, Munshi, Tariq, Yang, Mega, Adams, Clive E. and Farooq, Saeed (2015) Development, testing and reporting of mobile apps for psycho-social interventions: lessons from the pharmaceuticals. Journal of Medical Diagnostic Methods, 04 (04). 1000191/1-1000191/5. ISSN 2168-9784 mHealth; eHealth; Digital health; Psycho social interventions; Development; Reporting; Testing; Digital media https://www.omicsonline.org/open-access/development-testing-and-reporting-of-mobile-apps-for-psychosocialinterventions-lessons-from-the-pharmaceuticals-2168-9784-1000191.php?aid=65355 doi:10.4172/2168-9784.1000191 doi:10.4172/2168-9784.1000191
spellingShingle mHealth; eHealth; Digital health; Psycho social interventions; Development; Reporting; Testing; Digital media
Naeem, Farooq
Syed, Yumeen
Xiang, Shuo
Shokraneh, Farhad
Munshi, Tariq
Yang, Mega
Adams, Clive E.
Farooq, Saeed
Development, testing and reporting of mobile apps for psycho-social interventions: lessons from the pharmaceuticals
title Development, testing and reporting of mobile apps for psycho-social interventions: lessons from the pharmaceuticals
title_full Development, testing and reporting of mobile apps for psycho-social interventions: lessons from the pharmaceuticals
title_fullStr Development, testing and reporting of mobile apps for psycho-social interventions: lessons from the pharmaceuticals
title_full_unstemmed Development, testing and reporting of mobile apps for psycho-social interventions: lessons from the pharmaceuticals
title_short Development, testing and reporting of mobile apps for psycho-social interventions: lessons from the pharmaceuticals
title_sort development, testing and reporting of mobile apps for psycho-social interventions: lessons from the pharmaceuticals
topic mHealth; eHealth; Digital health; Psycho social interventions; Development; Reporting; Testing; Digital media
url https://eprints.nottingham.ac.uk/50110/
https://eprints.nottingham.ac.uk/50110/
https://eprints.nottingham.ac.uk/50110/